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Zagreb indices M1 and M2 have been refined to significantly reduce their degeneracy. The re-
fined indices are sensitive to both the presence as well as relative position of the heteroatoms
and have been termed as Zagreb topochemical indices M1
c and M2
c. The discriminating power
of M1
c and M2
c was investigated and compared with that of Zagreb indices M1 and M2. Both
M1
c and M2
c exhibited much lower degeneracy without compromising with the discriminating
power of M1 and M2. Relationship between the anti-inflammatory activity of N-arylanthranilic
acids and Zagreb indices and Zagreb topochemical indices was investigated. The values of all
the four indices for each of the 112 compounds were calculated using an in-house computer
program. The resulting data was analyzed and suitable models were developed after identifica-
tion of the active ranges. Subsequently, biological activity was assigned to each of the com-
pounds using these models, which was then compared with the reported anti-inflammatory ac-
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INTRODUCTION
N-Arylanthranilic acids belong to the category of non-
steroidal anti-inflammatory drugs. They are amino iso-
steres of salicylates and are also known as fenamates.
Important molecules of this class include mefenamic acid,
flufenamic acid and meclofenamic acid. As an analgesic
agent, mefenamic acid has been used to relieve pain aris-
ing from rheumatic conditions, soft tissue injuries, other
painful musculoskeletal conditions and dysmenorrhea.
Fenamates act by blocking the metabolism of arachido-
nic acid by the enzyme cyclooxygenase (COX), one of
the key enzymes in the arachidonic acid cascade.1,2 This
enzyme bis-oxygenates arachidonic acid to prostaglandin
G2, which is subsequently degraded to vasoactive and
inflammatory mediators such as prostaglandins (PGs),
prostacyclin (PGI2), and thromboxane-A2.
3 Some fena-
mates also inhibit arachidonic acid lipoxygenase result-
ing in decreased synthesis of leukotrines, known media-
tors involved in inflammatory process.4 Studies suggest
that flufenamic and tolfenamic acids suppress prolifera-
tion of human peripheral blood lymphocytes by a mech-
anism, which involves inhibition of Ca2+ influx and is
not related to inhibition of prostanoid synthesis.5 It has
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also been reported that substitution of the carboxylic acid
functionality of several fenamates with acidic heterocy-
cles provided dual inhibitors of CO and 5-lipoxygenase
(5-LO) activities when tested in an intact rat basophilic
leukemia (RBL-1) cell line. Nonsteroidal anti-inflamma-
tory drugs (NSAIDs) are a mainstay in the treatment of
inflammatory disease and are among the most widely
used drugs worldwide. They are anti-inflammatory, anti-
pyretic, and analgesic and are prescribed as first choice
for the treatment of rheumatic disorders and, in general,
inflammation.6 The non-steroidal anti-inflammatory drugs
(NSAIDs) are widely used for the treatment of minor
pain and for the management of edema and tissue dam-
age resulting from inflammatory joint diseases (arthritis)
and other inflammatory diseases. The main limitation in
using NSAIDs consists in their side-effects, including
gastrointestinal ulcerogenic activity and bronchospasm.6
Since NSAID therapy forms an integral part of treatment
of diseases like rheumatoid arthritis, osteoarthritis, acute
gouty arthritis, ankolysing spondylitis and dysmenorrhea
etc., search for newer, better and more effective agents is
always a concern for medicinal chemists.
The finding that structure of a molecule had an im-
portant role to play in its biological activity coupled with
the need for safer potent drugs to be developed with mi-
nimum expenditure, animal sacrifice and time loss led to
the genesis of structure-activity relationship (SAR) stud-
ies.7 SAR has been given due recognition in medicinal
chemistry and the pharmaceutical industry8,9 and is one
of the indispensable tools of the drug design. Use of top-
ological indices in SAR seems to play an important role
in situations where biological activity is determined pre-
dominantly by topological architecture of molecular struc-
ture, i.e. where simple connectivity among neighboring
atoms, without considering the chemical nature of atoms
or nature of chemical bonding, may be the major deter-
minant of the biological activity of a molecule.10 When a
single number represents a graph invariant, it is known
as topological index or topological descriptor. These in-
dices are derived from matrices, like distance matrix and/or
adjacency matrix, representing a molecular graph. When
the distance or adjacency matrix is weighted correspond-
ing to the heteroatom present within the molecule, the
matrix may be termed as chemical distance or chemical
adjacency matrix respectively. Indices or descriptors de-
rived form such matrices are known as topochemical in-
dices or descriptors. A number of topological and topo-
chemical indices have received great attention due to
their applications in quantitative structure activity rela-
tionship (QSAR) studies and drug research.11–15 Amongst
the most important ones are molecular connectivity in-
dex of Randi},16,17 Wiener’s index,18,19 Balaban’s indi-
ces,20,21 Hosoya index,22 Zagreb indices M1 and M2,
23–26
eccentric connectivity index27–29 and eccentric adjacency
index.30 Topochemical indices that have been reported
and used for SAR studies include atomic molecular con-
nectivity index,31 eccentric adjacency topochemical in-
dex,32 Wiener’s topochemical index33 and superadjacency
topochemical index34 etc.
In the present study, adjacency based Zagreb indices
M1 and M2 have been refined and the corresponding Zag-
reb topochemical indices have been proposed. The dis-
criminating power and degeneracy of the newly proposed
Zagreb topochemical indices has been investigated and
compared with the original indices. The relationship of
these indices with anti-inflammatory activity of N-aryl-
anthranilic acid derivatives has been investigated and
suitable models for the prediction of anti-inflammatory
activity have been developed.
Zagreb Indices M1 and M2. – This pair of indices
was introduced in 1972 (Ref. 35) and were given differ-
ent names in the literature, such as the Zagreb Group in-
dices, the Zagreb group parameters and most often, the
Zagreb indices. These indices are denoted by M1 and M2
and are defined as per the Eqs. (1) and (2).
M1 = d i d i
vertices
( ) ( ) (1)
M2 = d i d j
edges
( ) ( ) (2)
where d(i) is the degrees of vertex i and d(i)d(j) is the
weight of edge i,j.
Zagreb indices are referred to in most of the books
reporting topological indices and their uses in QSPR and
QSAR. They are also included in a number of programs
used for the routine computation of topological indi-
ces, such as POLLY, OASIS, DRAGON, Cerius, TAM,
DISSIM, etc. Recently, the Zagreb indices and their va-
riants have been used to study molecular complexity,
chirality, ZE-isomerism and hetero-systems whilst the
overall Zagreb indices exhibited a potential applicability
for deriving multi-linear regression models. Zagreb indi-
ces have been used by various researchers in their QSPR
and QSAR studies. Mathematical properties of Zagreb
indices have also been studied.23
METHODOLOGY
Calculation of Topochemical Indices
One of the major limitations of Zagreb indices are that they
do not consider the presence of heteroatom in a molecule.
The new indices are being presented as modifications of the
Zagreb indices to overcome this limitation. The refined Zag-
reb indices have been termed as Zagreb topochemical indices.
The newly derived indices are sensitive to both the presen-




Zagreb Topochemical Index M1
c. – It is defined as the sum-
mation of the squares of chemical degrees over all the verti-
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c cG( ) ( ( ))

 (3)
For hydrogen suppressed molecular graph (G), v1, v2 ...
vn are vertices, n is the number of vertices and the number
of first neighbors of a vertex vi is the chemical degree of
this vertex and is denoted by dc(i).
Zagreb Topochemical Index M2
c. – It is defined as the sum-
mation of chemical weights of all edges in hydrogen sup-
pressed molecular graph. It is expressed by Eq. (4).




c c cG( ) ( ( ) ( ))  (4)
where dc(i) dc(j) is the chemical weight of the edge i, j in
hydrogen suppressed molecular graph in and n is the num-
ber of edges.
The proposed Zagreb topochemical indices M1
c & M2
c
can be easily calculated from the chemical adjacency matrix
of hydrogen suppressed molecular structure. Chemical de-
gree for a vertex i is the sum of entries in a row i of chemi-
cal adjacency matrix. When the adjacency matrix is weighted
corresponding to the heteroatom present within the mole-
cule, the matrix may be termed as chemical adjacency ma-
trix. This matrix is obtained by substituting, row elements
corresponding to heteroatom, with relative atomic weight with
respect to carbon atom. Thus, in this matrix the non-zero
row elements of an adjacency matrix represent chemical
adjacency between the corresponding vertices in a molecu-
lar graph. Calculation of Zagreb indices and Zagreb topo-
chemical indices for three, five-member straight/branched
structures, containing only one nitrogen as heteroatom has
been exemplified in Figure 1. Discriminating power and
degeneracy of Zagreb topochemical indices has been inves-
tigated for all possible structures with 3, 4 & 5 vertices with
only one nitrogen as heteroatom and compared with that of
Zagreb indices (Figure 2 and Table I).
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Zagreb Index M1
M1 = d i d i
vertices
( ) ( ) = 14 = 16 = 20









( ) ( ( ))G 

 = 14.696 = 17.030 = 21.364
Zagreb Index M2
M2 = d i d j
edges
( ) ( ) = 12 = 14 = 16
Zagreb Topochemical Index M2
c




2 ( ) ( ( ) ( ))G   = 12.501 = 14.668 = 16.668
Figure 1. Calculation of Zagreb indices M1& M2 and Zagreb topochemical indices M1c & M2c for three five-member structures with only
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Figure 2. Values of Zagreb indices M1 & M2 and Zagreb topochemical indices M1c & M2c for all possible structures with 3, 4 & 5 vertices
with only one nitrogen as heteroatom.
Model Development and Analysis
A dataset comprising of 112 N-arylanthranilic acids (Figure
3) was selected.36,37 The values of Zagreb indices and Za-
greb topochemical indices were calculated using an in-house
computer program. Resulting data was analyzed and suitable
models were developed after identification of the active ran-
ges by maximization of moving average with respect to active
compounds (<35 % = inactive, 35–65 % = transitional, >65
% = active).33,38–40 Subsequently, each compound was as-
signed a biological activity using these models, which was
then compared with the reported anti-inflammatory activity36
(Table II). The biological activity was reported in terms of
minimum effective dose (MED) mg per kg (mg kg–1). In their
experiments, compounds were administered by gavage, and
their ability to suppress erythema developing in the skin of
depilated albino guinea-pigs, 2 h after exposure to UV radia-
tion, was measured on all-or-nothing basis. Compounds,
which were significantly more active than vehicle, were ad-
ministered at half the previous dose, until a dose was reached
for which the response was significantly less than that of a
reference level of phenylbutazone. This dose was recorded as
the MED.36 The compounds reportedly having MED greater
than 2.5 mg kg–1 were considered as inactive and those hav-
ing less than or equal to 2.5 mg kg-1 were considered to be
potentially active for the purpose of this study. The percent
degree of prediction was calculated from the ratio of number
of compounds with correctly predicted activity to that of to-
tal number of compounds present in the respective ranges of
the proposed models. The overall degree of prediction was
obtained from the ratio of total number of compounds with
correctly predicted biological activity to that of total number
of compounds in the active and inactive ranges. The percent
classification was obtained form the ratio of number of com-
pounds present in active and inactive ranges (excluding those
in transitional ranges) to the total number of compounds (Ta-
ble III).
RESULTS
The discriminating power and degeneracy of the Zagreb
topochemical indices was investigated by calculating and
analyzing the index values of all possible structures with
3, 4 and 5 vertices with only one nitrogen as heteroatom.
Their comparison with Zagreb indices is presented in
Table I. These results reveal that the Zagreb topochemi-
cal indices have much lower degeneracy when compared
to the corresponding topological indices. Further that, with
this modification, there has not been any effect on the
discriminating power of the Zagreb indices. The relation-
ship of the anti-inflammatory activities of N-arylanthra-
nilic acids with the Zagreb indices and Zagreb topoche-
mical indices has been investigated and the results have
been presented in Table III. Retrofit analysis of the data
in Table II and III reveal the following information with
regard to the models based upon various indices.
Zagreb Index M1
• This model comprises of four ranges viz. inactive
range (<95), lower transitional range (95–103), active
range (104–108) and upper transitional range (>108).
• 38 out 40 compounds in the inactive range were
predicted correctly. The correctly predicted compounds
had average MED of 97.20 mg kg–1
• 12 out of 15 compounds in the active range were
predicted correctly. The correctly predicted compounds
had average MED of only 1.13 mg kg–1
• The active range was ideally bracketed by transi-
tional ranges. The lower transitional range had 43 com-
pounds and the upper transitional range had 14 compo-
unds.
• The overall predictability of the model based upon
the Zagreb index M1 was 90.9 %.
Zagreb Topochemical Index M1
c
• This model comprises of four ranges viz. inactive
range (<113.25), lower transitional range (113.25–129.82),
active range (129.83–145.42) and upper transitional range
(>145.42).
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TABLE I. Comparison of discriminating power and degeneracy of the Zagreb indices M1 & M2 and the Zagreb topochemical indices M1c
& M2c
DISCRIMINATING POWER DEGENERACY(a)













Ratio Three Four Five
M1 6 12 1:2.00 10 36 1:3.60 14 66 1:4.71 1/3 5/11 34/48
M1
c 6.696 13.392 1:2.00 10.696 39.090 1:3.65 14.696 70.092 1:4.77 0/3 0/11 5/48
M2 4 12 1:3.00 8 54 1:6.75 12 120 1:10.00 1/3 5/11 29/48
M2
c 4.334 13.364 1:3.08 8.501 58.593 1:6.89 12.501 127.098 1:10.16 0/3 0/11 3/48









Figure 3. Structure of N-Arylanthranilic acids.
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1 H 78 84.50 88 93.50 – – – – –
2 2-Cl 84 106.08 96 113.74 – – – – –
3 3-Cl 84 106.08 95 110.29 – – – – –
4 4-Cl 84 106.08 95 110.29 – – – – –
5 2-CH3 84 90.50 96 101.67 – – – – –
6 3-CH3 84 90.50 95 100.50 – – – – –
7 4-CH3 84 90.50 95 100.50 – – – – –
8 3-NH2 84 91.53 95 101.34 – – – – –
9 3-n-C4H9 96 101.47 108 112.50 ± – – – –
10 3-SCH3 88 113.39 100 118.84 – – – – –
11 3-OC2H5 92 102.05 104 112.49 – – – – –
12 3-OCH3 88 97.39 100 108.17 – – – – –
13 3-n-C3H7 92 98.50 104 109.50 – – – – –
14 3-Br 84 156.62 95 128.84 – ± – – –
15 3-SO2N(CH3)2 112 164.37 130 185.95 ± ± ± ± –
16 3-C2H5 88 94.50 100 105.50 – – – – –
17 3-CN 88 95.20 100 106.17 – – – – –
18 3-NO2 94 106.69 107 118.34 – – – – –
19 3-C(=O)CH3 94 102.61 107 114.17 – – – – –
20 3-CF3 102 125.55 116 132.00 ± ± ± – –
21 3-N(CH3)2 94 102.25 107 114.67 – – – – –
22 2,3-Cl2 90 127.66 104 139.28 – ± – ± +
23 2-F, 3-Cl 90 115.92 104 126.74 – ± – – –
24 2-CH3, 3-Cl 90 112.08 104 121.42 – – – – –
25 2-Cl, 3-CH3 90 112.08 104 123.70 – – – – –
26 2-CH3, 3-NO2 100 112.69 116 127.67 ± – ± – –
27 2-CH3, 3-NH2 90 97.53 104 110.67 – – – – –
28 2,3-(CH3)2 90 96.50 104 109.67 – – – – –
29 2,6-Cl2, 3-C2H5 100 137.66 117 148.94 ± + ± + +
30 6-(CH3)2, 3-NO2 108 120.69 125 136.67 + ± + ± +
31 2-NH2, 3-Cl, 6-CH3 96 119.11 112 131.11 ± ± ± – –
32 2-NH3, 3,6-(CH3)2 96 103.53 112 119.03 ± – ± – –
33 2-CH3, 3-Cl, 6-NH2 96 119.11 112 130.61 ± ± ± – –
34 2-CH3, 3-NO2, 6-Cl 106 134.27 124 147.91 + + + + +
35 2-CH3, 3-NH2, 6-Cl 96 119.11 112 130.91 ± ± ± – –
36 2,6-(CH3)2, 3-NH2 96 103.53 112 118.84 ± – ± – –
37 2-Cl, 3,6-(CH3)2 96 118.08 112 131.87 ± ± ± – –
38 2,6-(CH3)2, 3-N(CH3)2 106 114.25 112 132.17 + ± + – +
39 2,3-Cl2, 6-CH3 96 133.66 112 147.45 ± + ± + +
40 2,3-Cl2, 3-OCH3 100 140.55 117 152.59 ± + ± + +
41 2,3,6-(CH3)3 96 102.50 112 117.84 ± – ± – –
42 2,6-(CH3)2, 3-Br 96 168.62 112 151.84 ± ± ± + +
43 2,6-(C2H5)2, 3-NO2 114 126.69 134 145.84 ± ± ± ± –
44 2,6-Cl2, 3-NH2 96 134.69 112 145.27 ± + ± ± –
45 2,6-Cl2, 3-N(CH3)2 106 145.42 124 158.61 + + + + +
46 2,6-(CH3)2, 3-C2H5 100 106.50 117 122.84 ± – ± – +
47 2,6-(CH3)2, 3-C(=O)CH3 106 114.61 124 131.50 + ± + – +
48 2,6-(CH3)2, 3-N-C3H7 104 110.50 121 126.84 + – + – –
49 2,6-(CH3)2, 3-CN 100 107.20 117 123.50 ± – ± – +
50 2-CH3, 3-OCH3, 6-Cl 100 124.97 117 137.91 ± ± ± ± +
51 2,6-Cl2, 3-OC2H5 104 145.22 121 156.93 + + + + +
52 2,6-(CH3)2, 3-SCH3 100 125.39 117 137.84 ± ± ± ± +
53 2,6-(C2H5)2, 3-SO2N(CH3)2 132 184.37 157 214.95 ± ± ± ± –
54 2,6-Cl2, 3-CF3 114 168.71 133 175.44 ± ± ± ± +
55 2,6-Cl2, 3-CN 100 138.36 117 149.61 ± + ± + +
56 2-CH3, 3-SO2N(CH3)2, 6-Cl 124 191.50 147 217.03 ± ± ± ± +
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57 2-CH3, 3-CN 94 101.20 109 115.34 – – – – –
58 2,3-Br2 90 228.73 104 216.40 – ± – ± –
59 2-Br, 3-CF3 108 197.67 125 181.78 + ± + ± +
60 2-CH3, 3-OCH3 94 103.39 109 117.67 – – – – –
61 2-Br, 3-CN 94 167.31 109 155.95 – ± – + +
62 2-CH3, 2-C2H5 94 100.50 109 114.67 – – – – –
63 2-CH3, 3-CF3 108 131.55 125 141.16 + + + ± +
64 2-CH3, 3-SO2N(CH3)2 118 170.37 139 196.79 ± ± ± ± –
65 2-CH3, 3-N(CH3)2 100 108.25 116 124.01 ± – ± – –
66 2,4-Cl2 90 127.66 103 130.53 – ± – – –
67 2,5-Cl2 90 127.66 103 133.99 – ± – – –
68 2,6-Cl2 90 127.66 104 135.83 – ± – – –
69 3,4-Cl2 90 127.66 103 138.83 – ± – – –
70 3,5-Cl2 90 127.66 102 127.08 – ± – – –
71 2,4-(CH3)2 90 96.50 103 108.67 – – – – –
72 2,5-(CH3)2 90 96.50 103 108.67 – – – – –
73 2,6-(CH3)2 90 96.50 104 109.84 – – – – –
74 3,4-(CH3)2 90 96.50 103 108.50 – – – – –
75 3,5-(CH3)2 90 96.50 102 107.50 – – – – –
76 3,5-(CF3)2 126 166.60 144 170.49 ± ± ± ± –
77 2-Cl, 6-CH3 90 112.08 104 121.91 – – – – –
78 2-CH3, 6-Cl, 3-N(CH3)2 106 129.84 124 144.25 + + + ± +
79 2,3,6-Cl3 96 149.25 112 159.53 ± ± ± + +
80 2,6-Cl2, 3-CH3 96 133.66 112 143.94 ± + ± ± +
81 2,6-(CH3)2, 3-Cl 96 118.08 112 129.58 ± ± ± – +
82 2-CH3, 3,6-Cl2 96 133.66 112 141.66 ± + ± ± +
83 2,3-(CH3)2, 6-Cl 96 118.08 112 129.91 ± ± ± – –
84 2,6-(CH3)2, 3-SO2N(CH3)2 124 176.37 147 204.95 ± ± ± ± +
85 2,6-(C2H5)2, 3-C(=O)CH3 114 122.61 134 141.50 ± ± ± ± –
86 2-(CH3)2, 3-CF3 116 139.55 136 152.33 ± + ± + +
87 2-Cl, 3-N(CH3)2, 6-CH3 106 129.84 124 146.53 + + + + +
88 2,6-Cl, 3-CN, 6-CH3 108 150.28 128 162.74 + ± + ± +
89 2,6-Cl2, 3-SO2N(CH3)2 124 207.53 147 234.33 ± ± ± ± +
90 2,6-(CH3)2, 3-SO2CH3 114 157.39 133 182.28 ± ± ± ± +
91 2,6-(CH3)2, 3-SOCH3 106 139.62 124 156.50 + + + + +
92 2,3,4-Cl3 96 149.25 112 164.82 ± ± ± ± –
93 2,3,5-Cl3 96 149.25 111 156.07 ± ± – + –
94 2,4,6-Cl3 96 149.25 111 150.78 ± ± – + –
95 2,4,5-Cl3 96 149.25 111 156.07 ± ± – + –
96 3,4,5-Cl3 96 149.25 111 161.37 ± ± – ± –
97 2,3,5-(CH3)3 96 102.50 111 116.67 ± – – – –
98 2,4,6-(CH3)3 96 102.50 112 117.84 ± – ± – –
99 2,4,5-(CH3)3 96 102.50 111 116.67 ± – – – –
100 2-CH3, 3,5-Cl2 96 133.66 111 138.21 ± + – ± +
101 2,3-Cl2, 5-CH3 96 133.66 111 146.28 ± + – ± –
102 3,5-Cl2, 4-CH3 96 133.66 111 140.00 ± + – ± –
103 2,5-(CH3)2, 3-Cl 96 118.08 111 128.42 ± ± – – +
104 2,3-(CH3)2, 5-Cl 96 118.08 111 126.46 ± ± – – –
105 2,3,4,5-Cl4 102 170.83 120 190.36 ± ± ± ± –
106 2,3,4,6-Cl4 102 170.83 120 185.07 ± ± ± ± –
107 2,3,5,6-Cl4 102 170.83 120 185.07 ± ± ± ± +
108 2,3,5,6-(CH3)4 102 108.50 120 125.84 ± – ± – –
109 2,3,4-Cl3, 6-CH3 102 155.25 120 172.99 ± ± ± ± –
110 2,4,6-Cl3, 3-CH3 102 155.25 120 163.69 ± ± ± ± –
111 2,3,4,5,6-Cl5 108 192.41 129 219.35 + ± ± ± –
112 2,3,5-(CH3)3, 4,6-Cl2 108 145.66 129 162.57 ± ± ± ± –
(a) – inactive compound, + active compound (MED mg kg –1 less than 2.5), ± compound in transitional range where biological activity could not
be specifically assigned.
TABLE II. continued
• 41 out 43 compounds in the inactive range were
predicted correctly. The correctly predicted compounds
had average MED of 104.72 mg kg–1.
• 15 out of 18 compounds in the active range were
predicted correctly. The correctly predicted compounds
had average MED of only 0.97 mg kg–1.
• The active range was ideally bracketed by transi-
tional ranges. The lower transitional range had 23 com-
pounds and the upper transitional range had 28 com-
pounds.
• The overall predictability of the model based upon
the Zagreb index M1 was 91.8 %.
Zagreb Index M2
• This model comprises of four ranges viz. inactive
range (<112), lower transitional range (112–120), active
range (121–128) and upper transitional range (>128)
• 48 out 52 compounds in the inactive range were
predicted correctly. The correctly predicted compounds
had average MED of 101.10 mg kg–1.
• 12 out of 13 compounds in the active range were
predicted correctly. The correctly predicted compounds
had average MED of only 1.13 mg kg–1.
• The active range was ideally bracketed by transi-
tional ranges. The lower transitional range had 33 com-
pounds and the upper transitional range had 14 com-
pounds.
• The overall predictability of the model based upon
the Zagreb index M1 was 92.3 %.
Zagreb Topochemical Index M2
c
• This model comprises of four ranges viz. inactive
range (<135.83), lower transitional range (135.83–146.29),
active range (146.30–159.53) and upper transitional range
(>159.53).
• 55 out 61 compounds in the inactive range were
predicted correctly. The correctly predicted compounds
had average MED of 85.34 mg kg–1
• 13 out of 16 compounds in the active range were
predicted correctly. The correctly predicted compounds
had average MED of only 0.98 mg kg–1
• The active range was ideally bracketed by transi-
tional ranges. The lower transitional range had 14 com-
pounds and the upper transitional range had 21 com-
pounds.
• The overall predictability of the model based upon
the Zagreb index M1 was 88.3 %.
DISCUSSION AND CONCLUSIONS
One of the current tendencies in chemical and biological
investigations is the prediction of physicochemical and
biological properties of chemical compounds and drugs
from their structures.41 Use of topological indices is now
one of the widely accepted computational tools for pre-
diction of activity/property of compounds. Topological
indices are designed by transforming a molecular graph
into a number and possess remarkable ability of being
able to correlate and predict a vide spectrum of proper-
ties for a vast range of molecular species.42 In the last
decade topological indices have played an important role
in the development of a number of drugs some of which
are now in the market or are going through clinical tri-
als.43 Although hundreds of topological indices have been
derived, still the theoretical chemists are striving to de-
velop, or modify the existing ones into better indices
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TABLE III. Zagreb topological/topochemical Models for anti-inflammatory activity of N-arylanthranilic acids
Model
Index














Total Correct Total Correct
M1 Inactive <95 40 38 95.0 92.43 97.20 90.9 49.1
Lower Transitional 95–103 45 N.A. N.A. N.A. N.A.
Active 104–108 15 12 80 9.65 1.13
Upper Transitional >108 12 N.A. N.A. N.A. N.A.
M1
c Inactive <114.25 43 41 95.4 99.89 104.72 91.8 54.5
Lower Transitional 114.25–129.82 23 N.A. N.A. N.A. N.A.
Active 129.83–145.42 18 15 83.3 6.88 0.97
Upper Transitional >145.42 28 N.A. N.A. N.A. N.A.
M2 Inactive <112 52 48 92.3 93.46 101.10 92.3 58.0
Lower Transitional 112–120 33 N.A. N.A. N.A. N.A.
Active 121–128 13 12 92.3 1.52 1.13
Upper Transitional >128 14 N.A. N.A. N.A. N.A.
M2
c Inactive <135.83 61 55 90.2 77.05 85.34 88.3 68.7
Upper Transitional 135.83–146.29 14 N.A. N.A. N.A. N.A.
Active 146.30–159.53 16 13 81.2 32.24 0.98
Lower Transitional >159.53 21 N.A. N.A. N.A. N.A.
which have much better applicability. In the present stu-
dy a pair of very well known and applied topological in-
dices, Zagreb indices have been refined to overcome their
limitation of degeneracy. The properties of the refined
indices, termed as Zagreb topochemical indices were in-
vestigated and compared with the original ones. Analysis
of the index values for all possible structures with 3, 4 and
5 vertices with only one nitrogen as heteroatom reveals
that the refined indices have much lower degeneracy when
compared to the original Zagreb indices. Degeneracy is
the measure of ability of an index to differentiate be-
tween the relative positions of atoms in a molecule. In
case of all possible structures with 3 and 4 vertices, no
degeneracy was reported with both the Zagreb topoche-
mical indices, whereas in case of structures with 5 verti-
ces, the degeneracy was reduced from 34/48 to 5/48 for
M1 and 29/48 to 3/48 for M2. For all possible structures
up to 5 vertices there has not been any adverse effect on
the discriminating power of the Zagreb indices. The dis-
criminating power is the ability of an index to convert
chemical structures into sufficiently distinct numerical
values taking into consideration compactness, branching,
and cyclicity. Thus in terms of degeneracy, the Zagreb
topochemical indices can be regarded as superior to the
Zagreb indices.
Zagreb indices and Zagreb topochemical indices were
used for the development of models for prediction of ac-
tivity of N-arylanthranilic acids. The dataset used in this
study comprises of 112 anti-inflammatory N-arylanthra-
nilic acids.36 Non-steroidal anti-inflammatory drugs have
always been a focus of development because of their wide
spread usage in routine and emergency conditions and
variety of actions like analgesic, anti-pyretic, anti-inflam-
matory, anti-rheumatic and anti-gout etc. All the four mod-
els, developed in this study, have shown excellent results
in terms of predictability (Table III). In all these models,
the activity lies in a narrow range of index values and
the active range is bracketed ideally by two transitional
ranges. This indicates the specificity of the active range
and that transition from the active range to the inactive
range is gradual. There is marginal difference between
the overall predictability of each of these models. The
model based upon M1
c has slightly higher predictability
than that based upon M1. Although amongst these, the
model based upon M2 has highest overall accuracy of
prediction i.e. 92.3 %, but the model based upon M2
c has
much higher classification i.e. 68.7 % when compared to
the other models (Table III). Therefore the model based
upon Zagreb topochemical index M2
c may be regarded
as better than the models based upon the other three in-
dices. Excellent predictability of the models is indicative
of the utility of these models in designing of newer N-
-arylanthranilic acids. These models can be easily explo-
ited to provide lead structures for the development of
potent therapeutic agents.
High discriminating power coupled with extremely
low degeneracy offer Zagreb topochemical indices vast
potential for structure activity/property studies.
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SA@ETAK
Predvi|anje protuupalnoga djelovanja N-arilantranilnih kiselina: Ra~unski pristup
temeljen na pobolj{anim Zagreba~kim indeksima
Sanjay Bajaj, S. Singh Sambi i Anil Kumar Madan
Zagreba~ki indeksi M1 i M2 pobolj{ani su s ciljem smanjivanja njihove degeneracije. Pobolj{ani Zagre-
ba~ki indeksi osjetljivi su na prisutnost i relativni polo`aj heteroatoma u molekuli. Nazvani su Zagreba~ki topo-
kemijski indeksi i ozna~eni su s M1
c i M2
c. Ispitan je diskriminatorski potencijal ovih indeksa i uspore|en s
onim koji pokazuju izvorni Zagreba~ki indeksi. Oba pobolj{ana Zagreba~ka indeksa, M1
c i M2
c, pokazuju znatno
ni`u degeneraciju od izvornih Zagreba~kih indeksa M1 i M2. Ispitane su relacije izme|u protuupalnoga dje-
lovanja N-arilantranilnih kiselina i izvornih Zagreba~kih indeksa i topokemijskih Zagreba~kih indeksa. Vrijed-
nosti indeksa za 112 N-arilantranilnih kiselina izra~unane su vlastitim programom. Dobiveni su vrlo to~ni modeli
odnosa protuupalnoga djelovanja tih kiselina i njihovih strukturnih parametera izra`enih pomo}u obiju vrsta
Zagreba~kih indeksa, ali je prednost na strani topokemijskih Zagreba~kih indeksa zbog njihove niske dege-
neracije.
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